drugset / Trial / NCT03050242

Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®)

NCT03050242

Completed 78 enrolled Eunah Cho, MD
RandomizedParallel-groupTriple-blindSupportive care

Summary

This study is intended to evaluate the efficacy and safety of glycopyrrolate as an antisialagogue prior to intubation with the rigid-videostylet(Optiscope®) in the general anesthesia settings. Upper airway secretions limit the use of the videostylet during during endotracheal intubation. Therefore, in this study, patients will be allocated to either of the two groups according to the administration of glycopyrrolate and the effect of glycopyrrolate in reducing oral secretions will be assessed by the observer while intubating with the rigid-videostylet. The efficacy of the antisialagogic effect on the view during endotracheal intubation will be evaluated.

Timeline

Start
2017-03-13
Primary completion
2017-05-18
Completion
2017-05-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrrolate Small molecule 0.005 mg/kg Intramuscular

Indications